Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.
about
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia - critical appraisal of suvorexantThe hypocretin/orexin system in sleep disorders: preclinical insights and clinical progressSuvorexant: a promising, novel treatment for insomniaUnmet needs of patients with narcolepsy: perspectives on emerging treatment optionsA Framework for Quantitative Modeling of Neural Circuits Involved in Sleep-to-Wake TransitionOrexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in MonkeysDifferential sleep-promoting effects of dual orexin receptor antagonists and GABAA receptor modulatorsA physiologically based model of orexinergic stabilization of sleep and wakeSuvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials.Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.Advances in the management of insomniaElectroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.Suvorexant, a dual orexin receptor antagonist for the management of insomnia.Suvorexant.Effects of Suvorexant, an Orexin Receptor Antagonist, on Respiration during Sleep In Patients with Obstructive Sleep Apnea.On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy VolunteersThe hypocretins and the reward function: what have we learned so far?Genes and primary headaches: discovering new potential therapeutic targets.On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.Orexin receptor antagonists as therapeutic agents for insomniaDiscovery and development of orexin receptor antagonists as therapeutics for insomnia.Sites of action of sleep and wake drugs: insights from model organisms.Suvorexant: The first orexin receptor antagonist to treat insomnia.Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors.Distinct effects of IPSU and suvorexant on mouse sleep architecture.Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report.Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.The Black Book of Psychotropic Dosing and Monitoring.DEC2 modulates orexin expression and regulates sleep.
P2860
Q26740978-E0FA86D7-B077-4D8F-95AE-FA382D3078B6Q26751277-DB1F8A34-FDFB-4776-8D23-8E900600DC01Q26767259-6BBDF2F7-5EBC-4967-A13B-D8A552CB6402Q26827736-C4736401-5403-4101-94D5-600C610DF8D7Q27016617-42A5CFFE-D23C-49F1-8EE6-7EBCD2DF6D5DQ27347707-C9594A93-9235-4C92-BDE1-32D166325938Q30375507-E21F5EE5-7831-4379-B5DD-36DD9F620598Q30423240-0F3B88DA-BF0A-4903-82BB-B0AE7993280DQ30441208-4407AA41-BEB0-47F3-8FFC-F2EE3C352DFBQ31113697-A8A13131-F634-4481-9093-0559ADA4BBFEQ31171354-437964CB-FA7C-4BE9-9D36-1D1A5198DF78Q33720437-B483AFDE-B0A2-469E-80A4-90C9D8F59498Q34238302-4CC36A02-D25A-4555-B22F-521CD39A6CF6Q34661456-61CEDFB4-96A4-4027-AFA2-A425E12577A3Q35063116-CE5FE558-A6F3-4E78-88FB-1FBF73434746Q36432739-232CCF83-793C-4B35-BCA0-E189B27B40B5Q36744112-4B5208D7-DB6E-4D02-9804-8656EF1CF3D8Q36923729-B134300D-0913-49EE-A90F-B26BE8418FFDQ37027988-EB2180A0-17BC-45C1-BDD9-3BD36093AA44Q37184429-8825BBDA-6429-4F0E-87E3-237E740F69C3Q37413138-29E9AE9A-9147-440F-8913-465F3C1C3113Q37522859-5D9738BD-A020-4FB8-9E8B-988999C5BB0DQ38109329-C97A8B66-A145-40BD-8988-D7D51403EFC1Q40250481-9A317D29-E145-41FA-9555-42AF1CFE95B1Q41998350-69AEBEB8-74C5-4491-BAEF-C776BDB05520Q42825760-6AB08732-FBDC-4CCA-B399-1BC9CADFA39AQ43236304-C9D623EF-40D2-4CFC-9CEC-6DDDEAB3C0DCQ47590020-E34594AF-2BF9-47DA-8FF6-D8BD7CF42DEEQ47642128-44BD5076-487B-4CB2-ACE8-9A22253993FFQ53435826-0AAF02E0-FB55-47C0-BD67-848B9C04ECC9
P2860
Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@en
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@nl
type
label
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@en
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@nl
prefLabel
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@en
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@nl
P2093
P2860
P356
P1433
P1476
Effects of suvorexant, an orex ...... olysomnography in healthy men.
@en
P2093
Christopher Lines
Darren Wilbraham
Eric Mangin
Gail M Murphy
Jeffrey Chodakewitz
Junshui Ma
Ka Lai Yee
Laura Rosen
Nicole Calder
P2860
P304
P356
10.5665/SLEEP.2386
P577
2013-02-01T00:00:00Z